Cellebrite DI Ltd.
CLBT
$14.44
-$0.09-0.62%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 23.41% | 25.82% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 23.41% | 25.82% | |
| Cost of Revenue | -- | -- | 17.62% | 18.74% | |
| Gross Profit | -- | -- | 24.54% | 27.22% | |
| SG&A Expenses | -- | -- | 18.82% | 20.05% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | 17.97% | 18.26% | |
| Operating Income | -- | -- | 71.14% | 101.18% | |
| Income Before Tax | -- | -- | -265.24% | -469.57% | |
| Income Tax Expenses | -- | -- | 26.84% | 65.37% | |
| Earnings from Continuing Operations | -- | -- | -248.96% | -433.77% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -248.96% | -433.77% | |
| EBIT | -- | -- | 71.14% | 101.18% | |
| EBITDA | -- | -- | 56.06% | 73.91% | |
| EPS Basic | -- | -- | -222.82% | -351.87% | |
| Normalized Basic EPS | -- | -- | 88.97% | -47.96% | |
| EPS Diluted | -- | -- | -211.52% | -338.84% | |
| Normalized Diluted EPS | -- | -- | 86.88% | -45.39% | |
| Average Basic Shares Outstanding | -- | -- | 10.16% | 6.38% | |
| Average Diluted Shares Outstanding | -- | -- | 10.15% | 3.53% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |